Headshot, Ramin Eskandari, M.D. (IMAGE)
Caption
By treating GMH mouse models with the complement inhibitor known as CR2Crry, Tomlinson and Eskandari found improved survival and weight gain, reduced brain injury and incidence of hydrocephalus, and improved motor and cognitive performances in adolescence.
Credit
Anne Thompson
Usage Restrictions
none
License
Original content